What is HDL Cholesterol (High-Density Lipoprotein Cholesterol)?
HDL particles are the smallest and most dense circulating lipoprotein class, synthesised by the liver and intestine and remodelled extensively in the circulation. They mediate reverse cholesterol transport — accepting free cholesterol from peripheral tissues and arterial macrophage foam cells via the ATP-binding cassette transporters ABCA1 and ABCG1, esterifying it via LCAT, and transferring it to the liver for excretion via CETP-mediated transfer to LDL and direct hepatic scavenger receptor BI (SR-BI) uptake. HDL particles also exert direct anti-atherogenic effects through anti-inflammatory, antioxidant, and endothelial protective mechanisms. HDL-C, however, measures only cholesterol mass within HDL particles — not HDL particle number or HDL functional capacity — and has shown less consistent therapeutic utility than LDL-C as a drug target, with HDL-raising drugs (niacin, CETP inhibitors) failing to reduce cardiovascular events despite raising HDL-C in clinical trials.